DRIVe Funding Opportunity #9

Digital Health Tools for Pandemic Preparedness

sepsis cells

Program Overview

To prepare for and to accelerate the public health response in the event of a future infectious disease epidemic or pandemic, DRIVe is interested in supporting the development of novel digital technologies that can serve as the first line of defense and augment existing medical countermeasures. Such digital health tools, including smartphone apps, social networks, telehealth, or other web applications, are intended to provide broadly available nowcasting and rapid response solutions, e.g. tools for monitoring the spread of an epidemic or pandemic, illness detection, risk assessment, clinical intervention support, and public health guideline dissemination, among others.

Specifically, DRIVe is seeking innovative, effective, equitable, affordable, easy-to-use, and broadly and rapidly available digital (data and analytics-based) health tools and applications with stringent privacy and data security safeguards.



An empowered citizenry – individuals, organizations, public health professionals, – armed with rapidly deployable digital health tools that can serve as the first line of defense and a complement to other medical countermeasures against a future pathogen outbreak


To support the development of a suite of innovative, effective, and broadly available digital tools that support our pandemic preparedness efforts through outbreak prediction, infection detection, and preventive health.

Program FAQ

Learn about our Digital Health Tools for Pandemic Preparedness program by checking out our frequently asked questions

Is this Area of Interest open to academics or do only companies qualify?

It is open to both academia and industries as long as the respondents meet all the requirements described in the EZ-BAA and the special instructions .

Any entity can submit proposal via the EZ-BAA portal as long as they are registered with

Yes. Applicants from outside of the United States are eligible to apply for funding.

Yes. Abstract submissions should include a cost-share that is within our target range of minimum 30-50% minimum ,unless you satisfy the regulatory exception (included below for reference). Currently, none of the DRIVe partners under the DRIVe EZ-BAA have been awarded a contract that does not include a cost-share component below range, including all universities and non-profit organizations. Cost-share may be in-kind or cash contributions. It may also come from a third-party investor/sponsor, however, it is up to you to ensure you receive their contribution toward the proposed project. Many organizations offer to cover Overhead or Fringe Benefits. Some also offer pro-bono labor hours or sponsored equipment, materials, or subcontractor costs. A combination of all of the above could be acceptable. It would need to be indicated on a submission what is being cost-shared. To qualify for no cost-share under an EZ-BAA award, a respondent must show that there is "no probability that the respondent will receive present or future benefits from participation as described in Federal Acquisition Regulation (FAR) 16.303." Examples of present or future benefits include increased technical know-how, training for employees, acquisition of goods or services, development of a commercially viable product that can be sold in the commercial market, and use of background knowledge in future contracts.

Projects funded under this program have data sharing requirements with the U.S. government consistent with government regulation (FAR 52.227-14 Rights in Data). The program requires that you share all data (including raw data) generated under the project for government use consistent with the regulation.

While you can include links to figures or references, it is not mandated that reviewers view that outside information. At this time, the abstract format does not accept any figures, only text.

Digital Health Partners

CVS Health Clinical Trials
CVS Health Clinical Trials


Check back for future webinars

Submit your EZ BAA Abstract

For more information, please contact us at